Simplex Trading’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
Simplex Trading's SOPH Position: Q1 2026 in Review
Simplex Trading sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 31 shares — an estimated $151 sold.
Simplex Trading first reported a position in SOPH in Q2 2023 and held it in 3 quarters. The position peaked at $4K in Q3 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- Simplex Trading reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 31 SOPHiA GENETICS shares in Q1 2026, an estimated $151.
- Simplex Trading first reported a position in SOPHiA GENETICS in Q2 2023 and held it in 3 quarters.
- Simplex Trading's SOPHiA GENETICS position peaked at $4K in Q3 2025.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.